Form 4 holding
10%+ Owner
PRECISION BIOSCIENCES INC
- Security class
- Common Stock
- Shares / value
- 12,407,440
- Estimated value
- $4,590,753
- Report date
- 15 Jun 2022
- Price
- $0.3700
- Ownership
- Direct
NOVARTIS PHARMA AG
Insider Reports History
- Reporting-owner location
- Basel, Switzerland
- Latest reporting-owner signature
-
Novartis Pharma AG /s/ Christian Rehm, Authorized Signatory /s/ Lukas Foertsch, Authorized Signatory
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for NOVARTIS PHARMA AG
Insider Reports Filed by NOVARTIS PHARMA AG
3
DTIL
PRECISION BIOSCIENCES INC
- Report period
- 15 Jun 2022
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 27 Jun 2022, 16:38
- Role
- 10%+ Owner
- Next action
- Open filing details